• Media Coverage
• May 29, 2013
• GigOm

Will the Supreme Court Kill the Gene-Patent Business?

• Media Coverage
• May 23, 2013
• San Francisco Business Times

QB3, Partnership to Open New, Large Life Sciences Incubator

• Media Coverage
• May 20, 2013
• xconomy

Zillions of Biotech Conferences Want You. Which Should You Attend?

• Media Coverage
• April 30, 2013
• KQED

Biotech Entrepreneurship and Startup Culture Lure Scientists Away from Their Labs

• April 29, 2013

Chancellor Highlights Value of Academic-Industry Partnerships in Boosting Scientific Research

• December 13, 2011

UCSF Chancellor Susan Desmond-Hellmann Featured on BioCentury This Week

<p>UCSF Chancellor Susan Desmond-Hellmann, MD, former president for product development at Genentech, is featured in a video interview for BioCentury Publications Inc., a major biopharmaceutical news media source, which first aired online on Dec. 11.</p>

• Media Coverage
• November 28, 2011
• San Francisco Business Times

The Birth of Biotech

• Media Coverage
• November 8, 2011
• Forbes

Cyborg Yeast Have Their Genes Controlled by Computer

• Media Coverage
• November 6, 2011
• BBC News

'Cyborg' Yeast Genes Run by Computer

• Media Coverage
• September 14, 2011
• xconomy

Computing in the Age of the $1,000 Genome. Our Next Big Event in SF Oct. 24

• Media Coverage
• September 2, 2011
• ZDNet

Dreamforce: UCSF Converting Science into Public Benefit

• Media Coverage
• July 25, 2011
• FastCompany

How Scientists And Engineers Got It Right, And VCs Got It Wrong

• June 30, 2011

UCSF Names Lium to Lead New Innovation Office

<p>Erik Lium has been named assistant vice chancellor of UCSF's newly created Office of Innovation, Technology and Alliances to&nbsp;provide the strategic leadership to both support innovation on campus and foster external alliances to advance biomedical research.</p>

• Media Coverage
• May 29, 2011
• San Francisco Chronicle

AIDS: Bay Area Leadership Brings Hope to Epidemic

• Research
• May 5, 2011

UCSF Scientists Play Key Role in Success of Yervoy, a New Cancer Drug

<p>Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma –&nbsp;and that is being used to treat other cancers in ongoing clinical trials –&nbsp;is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.</p>